BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia |
Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD |
'A' Award Grants |
2012 |
New York |
Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute / David Pellman, MD |
Innovation Grants |
2012 |
Massachusetts |
Casein Kinase 1 alpha Agonists as Novel Medulloblastoma Inhibitors |
University of Miami Miller School of Medicine / David Robbins, PhD |
Innovation Grants |
2012 |
Florida |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Racial and Ethnic Disparities in Survival of Children with Neuroblastoma |
University of Chicago / Susan Cohn, MD |
Innovation Grants |
2011 |
Illinois |
The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma |
Duke University / Michael Armstrong |
Young Investigator Grants |
2011 |
North Carolina |
Mechanisms of Oncogenic Transformation by TLX1/HOX11 |
University of Michigan / Mark Chiang |
Young Investigator Grants |
2011 |
Michigan |
Identification of Alveolar Rhabdomyosarcoma "Achilles' Heel" |
National Cancer Institute / Fernanda Arnaldez |
Young Investigator Grants |
2011 |
Maryland |
Preliminary Content Validation Steps for the Pediatric Oncology Patient Self-Report CTCAE |
Children’s National Medical Center / Pamela Hinds |
Nurse Researcher Grants |
2011 |
District of Columbia |
BH3 Profiling to define therapy resistance classes in neuroblastoma |
Children’s Hospital of Philadelphia / Michael Hogarty, MD |
Innovation Grants |
2011 |
Pennsylvania |